Unchained Labs opens new contract testing facility at its CA headquarters

By Maggie Lynch

- Last updated on GMT

(Image: Getty/seventyfour)
(Image: Getty/seventyfour)
Unchained Labs’ new facility will support its North American customers with specialized services in particle identification and visibility.

The new contract testing lab is located in Pleasanton, California along with its headquarters.

The company currently has a contract testing lab in Berlin, Germany that supports its European customers. Though Unchained Labs recently closed its other lab in New Jersey, therefore, requiring additional space in North America.

Located in Pleasanton, the new lab, also benefits the contract testing team as its members are now located at the same site as its product development and science teams, according to Taegen Clary, VP of marketing at Unchained Labs.

"The new Pleasanton contract testing lab makes it easier for more customers in North America to take advantage of these services and expands capacity beyond our current test lab in Europe,” ​Clary stated.

The lab will handle the identification of unwanted particles in drug products and quality assessment of silicone layers on drug delivery devices. Additionally, the new space will give the company the capability to take on more projects and provide clients and sponsors with faster results.

“Because we provide specialized services, CROs [contract research organizations] often refer their clients to us if they do not have the tools or expertise to take on these types of projects themselves,”​ Clary told us.

The company stated that two of its instruments are the most often used for contract testing. These instruments include the instrument known as Hound, which determines the count, size, shape, and identity of visible particles with spectroscopy.

Bouncer, the second instrument, can be used to measure the silicone thickness and distribution on syringes, cartridges, and vials for particles in the sub-visible range.

"If someone has particle problems or wants to confirm that the right amount of silicone is on their device, we've got their back,"​ said Clary in a statement.

Related news

Show more

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Unlock potential in buffer preparation

Unlock potential in buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 18-Sep-2023 | Infographic

Consider how the right partner can help you scale faster, mitigate risks, and optimize resources.

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 14-Aug-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Designing an Optimal APAC Clinical Supply Chain

Designing an Optimal APAC Clinical Supply Chain

Content provided by Catalent | 08-Mar-2023 | Infographic

With clinical study activity increasing across the Asia-Pacific region, it is important for sponsors—both in APAC and globally—to understand the broader...

Follow us

Products

View more

Webinars